Montana State Senator Calls for a Federal Hemp Ban
Montana state Sen. Mark Noland warns Congress not to let the hemp lobby delay the ban again.

Though Tim Sheehy, the U.S. senator for Montana, has cozied up to the for-profit hemp industry and called for a federal hemp framework, Mark Noland, a state senator from Montana, recently wrote in the Lake County Ledger: “I am asking for the Montana Congressional delegation to preserve our health and safety by opposing any sort of extension or reopening of the federal hemp loophole.”
Noland, who noted that he has 12 grandchildren, stated, “keeping our young Montanans out of harm’s way remains a top-priority.”
He pointed to Montana HB 948, passed in 2023, which banned hemp-derived products, as well as synthetic THC products, in Big Sky Country. He explained, “The state legislature took action after a rise in youth hospitalizations from intoxicating hemp products.”
“The most dangerous part is the industry that has been built around them,” Noland, a Republican, argued, adding that “hemp products have been found on the shelves of gas stations and convenience stores, frequently targeting younger demographics by marketing their products to mimic common snack and candy brands.”
Get stories like this every Friday
The week's drug policy news in one email, every claim sourced. Join tens of thousands of readers.
In turn, Montana has one of the nation’s highest rates of youth hemp use. In 2023–2024, 16.8% of 12–17-year-olds in Montana said they had ever used hemp or CBD, up from the national average of 13.1%, according to the National Survey on Drug Use and Health. During that time period, Montana was one of only five states where more than 50% of 18–25-year-olds reported ever trying hemp or CBD.
Why Noland Wants a Federal Hemp Ban
Beyond the inherent health-related harms of hemp, Noland was concerned with how hemp is produced. He said, “manufacturers are known to use toxic and corrosive solvents and heavy metal catalysts, remnants of which can be found in final products.”
Noland added that some synthetic THC is “being sourced from Chinese chemical suppliers.”
As such, Noland argued, “Congress cannot allow for these dangerous substances to freely circulate in communities across Montana or anywhere else in the country. It amounts to a backdoor legalization of THC and violates the very decisions about these drugs states have made.”
The Federal Hemp Ban Was Already Delayed Once
The federal hemp ban was initially scheduled to take effect on November 12th but was postponed to December 11th, which has given pro-hemp individuals like Sheehy additional time to attempt to save hemp.
Noland noted, “The hemp lobby already pushed to delay this closure once, and it cannot happen again.”
Dr. Kevin Sabet, President and CEO of Smart Approaches to Marijuana (SAM), called the Sheehy-Klobuchar bill “dead on arrival,” stating, “This bill doesn’t add guardrails; it removes them. It wipes out the limit on THC per container and more than triples the amount of THC a product can contain and still be called hemp, which could allow a single 12-ounce drink to hold roughly 3,500 milligrams of THC, or 700 standard doses.”
Sabet added, “The question is simple: will Congress keep its word to America’s kids and put them first, or will they cow to this addiction industry?”
Noland’s call has been echoed by numerous trusted individuals and organizations. In August 2026, a coalition of 35 Attorneys General, representing 34 states and the Virgin Islands, called on Congress to close the hemp loophole. In September 2025, the Addiction Policy Forum, American Academy of Addiction Psychiatry, American Academy of Pediatrics, CADCA, DEA Educational Foundation, DuPage County Health Department, International Academy on the Science and Impact of Cannabis, Johnny’s Ambassadors, National Association for Children of Addiction, Shatterproof, Smart Approaches to Marijuana, Song for Charlie, Washington State Public Health Association, and more signed a letter calling for a “comprehensive ban” on hemp.
Get The Drug Report every Friday
One free email every Friday: the week's drug policy news, sourced and explained. Read by tens of thousands of people who write, enforce and cover the policy. Unsubscribe anytime.
